James J. Egan J.D. ’75 was recently appointed Chief Operating Officer of Sucampo Pharmeceuticals, Inc. He joins Sucampo from ESBATech AG, a privately-held biotech company in Zurich, Switzerland, where he was Chief Business Officer with responsibility for corporate and financing strategies and corporate strategic planning. Prior to joining ESBATech, Mr. Egan was Senior Vice President, Licensing & Corporate Development at Idenix Pharmaceuticals, Inc., a Cambridge, Massachusetts-based biotech company.